UBS ETF Please confirm that you are resident in Norway to proceed.

ETF Comparison

UBS ETF (IE) MSCI China A SF UCITS ETF (USD) A-acc

ISIN IE00BKFB6K94
Replication Synthetic
Asset class Equities
Fee 0.30%

Select a fund for comparison

Name of fund

UBS (Irl) Fund Solutions plc – MSCI China A SF UCITS ETF

Share class

UBS (Irl) Fund Solutions plc – MSCI China A SF UCITS ETF (USD) A-acc

ISIN

IE00BKFB6K94

Asset Class

Equities

Fund domicile

IE

Fund type

open-end

Benchmark

MSCI China A Total Return Net Index

UCITS V

yes

Launch date

18.02.2020

Currency of share class

USD

Accounting year end

30 June

Replication methodology

Synthetic (Fully Funded + Total Return Swap)

  • The investment objective of the fund is to deliver the net total return performance of the MSCI China A Index less costs.
  • The Fund replicates synthetically the index performance by investing in a swap.
  • The swap counterparty transfers collateral to the ETF in the form of G10 government bonds, supranational bonds and cash.
  • The fund is passively managed.

Flat fee p.a.

0.30%

Total expense ratio (TER) p.a.1)

0.30%

  • The Reference Index captures large and mid-cap representation across China securities listed on the Shanghai and Shenzhen exchanges. The index covers only those securities that are accessible through "Stock Connect" (a unique collaboration between the Hong Kong, Shanghai and Shenzhen Stock Exchanges, Stock Connect allows international and Mainland Chinese investors to trade securities in each other's markets through the trading and clearing facilities of their home exchange). The index is calculated using China A Stock Connect listings based on the offshore RMB exchange rate (CNH). The Reference Index is based on the MSCI Global Investable Market Indexes (GIMI).

For marketing and information purposes by UBS.

For professional clients. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document.

UBS funds under Luxembourg and Irish law

Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management 

This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.

Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm.

© UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.